Veraxa Biotech AG - Post de-SPAC VRXA SEC Filings

NASDAQ VRXA
$1.65 +0.06 (+3.77%)
At close: Sep 10, 2026 · 4:00 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Veraxa Biotech AG - Post de-SPAC (VRXA) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index